Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
or for patients with diabetes and at high risk of liver fibrosis, as there are potential beneficial effects on MASLD.(4) Studies of GLP-1 RA Use in Patients with Cirrhosis A retrospective study in Taiwan, using matched pairs in which half of the patients used GLP-1 RAs, and the other half did not, included patients with type 2 diabetes and compensated cirrhosis
Protocol 2: Body recomposition (lose fat, build muscle) Goal: Improve body composition without necessarily dropping significant scale weight Stack: AOD 9604: 500mcg daily CJC-1295/Ipamorelin: 200mcg each before bed BPC-157: 250mcg twice daily (recovery) Moderate calorie deficit: 250-500 below maintenance Progressive resistance training: 4-5x per week Duration: 16-24 weeks minimum Expected results: 10-15 pounds fat loss 5-8 pounds muscle gain Net scale weight: -5 to -10 pounds Look dramatically different despite modest weight change Why this works: AOD 9604 burns fat
John Swann: She used her own name, uh, explained that she wanted to lose a few pounds, even though she herself was, stood 55 and weighed 123 pounds
